Skip to content
TheChatArchiveThe Chat Archive
Perplexitysonar-reasoning-pro-high· PerplexityHugging Face LMArena Search Arena 24K

why MaxQuant, when determining peptides by sequence, if you use all possible sites,…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with gpt-4o-search-preview’s answer.
  1. User

    why MaxQuant, when determining peptides by sequence, if you use all possible sites, sometimes removes amino acids one before the end? which peptidase does this?

  2. Perplexity Assistant

    MaxQuant sometimes removes amino acids one position before the end of peptides during peptide sequence determination due to the activity of carboxypeptidases. When you select "all possible sites" in MaxQuant, the software attempts to model the natural processing of peptides that occurs in biological samples.

    Carboxypeptidases are the specific peptidases responsible for this C-terminal processing. These enzymes catalyze the sequential removal of amino acids from the C-terminus (end) of peptides and proteins[5]. Unlike aminopeptidases that cleave from the N-terminus[8], carboxypeptidases specifically target the C-terminal end.

    This processing is biologically relevant because:

    1. Carboxypeptidases in pancreatic juice naturally break off the C-terminal amino acid during protein digestion[5].

    2. Certain amino acids are rarely found at the C-terminus of naturally occurring bioactive peptides. Some search algorithms avoid peptides ending with specific amino acids such as GPEDQNTSC[6].

    3. The "Proline rule" states that peptides generally should not end in a proline residue, which is considered "ultra-forbidden" at the C-terminus[6].

    MaxQuant, especially when integrated with its Andromeda search engine, takes these biological processing events into account when identifying peptides from mass spectrometry data[1]. When "all possible sites" is enabled, the software considers various post-translational modifications and processing events, including potential C-terminal cleavage by carboxypeptidases.

    This approach helps MaxQuant generate more biologically relevant peptide identifications and improves the accuracy of matching theoretical peptide sequences to mass spectrometry data, ultimately leading to more reliable protein identification and quantification.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.